Search research articles
Contact Us
Filters
Showing results (21-30 of 965) with videos related to
Page
of 97
Sort By:
Cancer Research Communications
|
October 22, 2025
Xevinapant plus chemoradiotherapy negatively sculpts the tumour immune microenvironment in head and neck cancer
Charleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev, et al.
Cancer Research Communications
|
October 20, 2025
Impact of Tumor Burden on Immune Checkpoint and Conventional Therapy Responses and Outcomes
Prashanth Gowda, Saiabhiroop R Govindu, David Hsiehchen
Cancer Research Communications
|
October 3, 2025
Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment-dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
Eleonora Y Khlebus, Veena K Vuttaradhi, Sammy Ferri-Borgogno, et al.
Cancer Research Communications
|
September 26, 2025
Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification
Adel T Aref, Jason Grealey, Mohashin Pathan, et al.
Cancer Research Communications
|
July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Nadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Cancer Research Communications
|
July 2, 2025
The XPO1 Inhibitor Eltanexor Modulates the Wnt/β-Catenin Signaling Pathway to Reduce Colorectal Cancer Tumorigenesis
Andrew E Evans, Sahida Afroz, Alexa Magstadt, et al.
Cancer Research Communications
|
June 30, 2025
Assessing Racial Disparities in Guideline-Concordant Care and Clinical Outcomes after Surgical Resection of Nonmetastatic Colon Cancer at a Comprehensive Cancer Center
Christina I Lee, Sharafudeen D Abubakar, Fan Wu, et al.
Cancer Research Communications
|
June 25, 2025
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Philippe A Cassier, Mitesh J Borad, Sunil Sharma, et al.
Cancer Research Communications
|
April 29, 2025
Preclinical Activity of Datopotamab Deruxtecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2, in Uterine Serous Carcinoma
Michelle Greenman, Cem Demirkiran, Stefania Bellone, et al.
Cancer Research Communications
|
April 22, 2025
Mucosal Microbiome Markers of Complete Pathologic Response to Neoadjuvant Therapy in Rectal Carcinoma
Ibrahim M Abukhiran, Amr H Masaadeh, James D Byrne, et al.
Page
of 97
Search research articles
Search
Showing results (21-30 of 965) with videos related to
Sort By:
Page
of 97
Cancer Research Communications
|
October 22, 2025
Xevinapant plus chemoradiotherapy negatively sculpts the tumour immune microenvironment in head and neck cancer
Charleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev, et al.
Cancer Research Communications
|
October 20, 2025
Impact of Tumor Burden on Immune Checkpoint and Conventional Therapy Responses and Outcomes
Prashanth Gowda, Saiabhiroop R Govindu, David Hsiehchen
Cancer Research Communications
|
October 3, 2025
Multiplexed Imaging Mass Cytometry Reveals Tumor-immune Microenvironment-dependent Hormone Receptor Expression in Adult-Type Ovarian Granulosa Cell Tumors
Eleonora Y Khlebus, Veena K Vuttaradhi, Sammy Ferri-Borgogno, et al.
Cancer Research Communications
|
September 26, 2025
Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification
Adel T Aref, Jason Grealey, Mohashin Pathan, et al.
Cancer Research Communications
|
July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
Nadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Cancer Research Communications
|
July 2, 2025
The XPO1 Inhibitor Eltanexor Modulates the Wnt/β-Catenin Signaling Pathway to Reduce Colorectal Cancer Tumorigenesis
Andrew E Evans, Sahida Afroz, Alexa Magstadt, et al.
Cancer Research Communications
|
June 30, 2025
Assessing Racial Disparities in Guideline-Concordant Care and Clinical Outcomes after Surgical Resection of Nonmetastatic Colon Cancer at a Comprehensive Cancer Center
Christina I Lee, Sharafudeen D Abubakar, Fan Wu, et al.
Cancer Research Communications
|
June 25, 2025
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Philippe A Cassier, Mitesh J Borad, Sunil Sharma, et al.
Cancer Research Communications
|
April 29, 2025
Preclinical Activity of Datopotamab Deruxtecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2, in Uterine Serous Carcinoma
Michelle Greenman, Cem Demirkiran, Stefania Bellone, et al.
Cancer Research Communications
|
April 22, 2025
Mucosal Microbiome Markers of Complete Pathologic Response to Neoadjuvant Therapy in Rectal Carcinoma
Ibrahim M Abukhiran, Amr H Masaadeh, James D Byrne, et al.
Page
of 97